Overview
- 182 inspections across 147 sites are on record.
- 220 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-03-07.
At a glance
Inspections
182
Sites
147
Observations
220
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Aeon Biotherapeutics Corp. | 7 Mar 2025 | Biologics | View 483 → |
| Oregon Health & Science University | 10 Aug 2022 | Biologics | |
| Oregon Health & Science University | 9 Aug 2022 | Biologics | |
| Oregon Health and Science University | 9 Aug 2022 | Biologics | |
| ATSF NE Office | 4 May 2022 | Biologics |
Sites inspected
Aeon Biotherapeutics Corp.New Taipei City, Taiwan1 insp.
Oregon Health & Science UniversityPortland, United States1 insp.
Oregon Health & Science UniversityPortland, United States1 insp.
Oregon Health and Science UniversityPortland, United States1 insp.
ATSF NE OfficeKimberly, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Dianna D Wardlow-Dotter15 shared
Vanessa Y Gelsey9 shared
Vanessa Y Jacobs7 shared
Dan G Eisenbrey6 shared
Mark W Babbitt5 shared
Ava M Bowman5 shared
Donald W Jehn4 shared
Gloria J Baca4 shared
Sunitha K Rajaram3 shared
Peter S Kessler3 shared
Full investigator report
Get the verbatim findings behind Alexander M Kay's 220 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site